These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 29716538
1. Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis. Liu J, Chen ZL, Li M, Chen C, Yi H, Xu L, Tan F, Peng FH. BMC Neurol; 2018 May 01; 18(1):58. PubMed ID: 29716538 [Abstract] [Full Text] [Related]
2. Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without ventriculomegaly. Corti M, Priarone M, Negroni R, Gilardi L, Castrelo J, Arechayala AI, Messina F, Franze O. Rev Soc Bras Med Trop; 2014 Jul 01; 47(4):524-7. PubMed ID: 25229298 [Abstract] [Full Text] [Related]
4. Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure. Li M, Liu J, Deng X, Gan Q, Wang Y, Xu X, Jiang Y, Peng F. BMC Infect Dis; 2020 Nov 16; 20(1):844. PubMed ID: 33198666 [Abstract] [Full Text] [Related]
5. Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus. Liliang PC, Liang CL, Chang WN, Lu K, Lu CH. Clin Infect Dis; 2002 Jun 15; 34(12):E64-8. PubMed ID: 12032912 [Abstract] [Full Text] [Related]
6. A comparison of the surgical outcomes of ventriculoperitoneal versus lumbar peritoneal shunts in the management of intracranial hypertension secondary to cryptococcal meningitis in HIV infected adult patients. Mabovula NS, Enicker BC. Clin Neurol Neurosurg; 2024 Mar 15; 238():108184. PubMed ID: 38394855 [Abstract] [Full Text] [Related]
7. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. Surg Neurol; 2005 Jun 15; 63(6):529-31; discussion 531-2. PubMed ID: 15936373 [Abstract] [Full Text] [Related]
10. Risk factors and outcomes of cerebrospinal fluid overdrainage in HIV-negative patients with cryptococcal meningitis after the ventriculoperitoneal shunting procedure. Hung CW, Lin WC, Chang WN, Su TM, Kung CT, Tsai NW, Wang HC, Huang CC, Cheng BC, Su YJ, Chang YT, Su CM, Hsiao SY, Lu CH. J Microbiol Immunol Infect; 2018 Aug 01; 51(4):545-551. PubMed ID: 28693927 [Abstract] [Full Text] [Related]
11. Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients. Tao R, Xu L, Guo Y, Xu X, Zheng J, Zhu B. BMC Infect Dis; 2022 Mar 26; 22(1):286. PubMed ID: 35351023 [Abstract] [Full Text] [Related]
12. Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus. Petrou P, Moscovici S, Leker RR, Itshayek E, Gomori JM, Cohen JE. J Clin Neurosci; 2012 Aug 26; 19(8):1175-6. PubMed ID: 22658489 [Abstract] [Full Text] [Related]
13. Clinical features and risk factors of surgical site infections in HIV-negative patients with cryptococcal meningitis underwent ventriculoperitoneal shunt operations: a retrospective study. Xu L, Zhu J, Wang X, Zeng G, Gao Z, Liu J. BMC Infect Dis; 2022 Sep 14; 22(1):736. PubMed ID: 36104794 [Abstract] [Full Text] [Related]
14. Nomogram to Predict the Outcome of Ventriculoperitoneal Shunt Among Patients with Non-HIV Cryptococcal Meningitis. Cao C, Luo L, Hu Y, Huang T, Gao S, Ling C, He H, Guo Y. World Neurosurg; 2024 Jun 14; 186():e305-e315. PubMed ID: 38552785 [Abstract] [Full Text] [Related]
15. Evaluation of ventriculoperitoneal shunt in the treatment of intracranial hypertension in the patients with cryptococcal meningitis: a report of 12 cases. Wang H, Ling C, Chen C, He HY, Luo L, Ning XJ. Clin Neurol Neurosurg; 2014 Sep 14; 124():156-60. PubMed ID: 25058911 [No Abstract] [Full Text] [Related]
16. Cerebrospinal Fluid Shunting in Children with Hydrocephalus and Increased Intracranial Pressure Secondary to Human Immunodeficiency Virus-Related Cryptococcal Meningitis. Enicker B, Aldous C. World Neurosurg; 2022 Dec 14; 168():e530-e537. PubMed ID: 36228933 [Abstract] [Full Text] [Related]
17. Efficacy of ventriculoperitoneal shunting in patients with cryptococcal meningitis with intracranial hypertension. Liu Y, Peng X, Weng W, Zhu J, Cao H, Xie S. Int J Infect Dis; 2019 Nov 14; 88():102-109. PubMed ID: 31499210 [Abstract] [Full Text] [Related]
18. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis. Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM, Lin PC, Ho MW, Wang JH. J Microbiol Immunol Infect; 2012 Aug 14; 45(4):296-304. PubMed ID: 22608531 [Abstract] [Full Text] [Related]
19. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. Qu J, Zhou T, Zhong C, Deng R, Lü X. BMC Infect Dis; 2017 Jan 10; 17(1):51. PubMed ID: 28068915 [Abstract] [Full Text] [Related]
20. Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. Mehta GU, Panackal AA, Murayi R, Bennett JE, Williamson PR, Chittiboina P. J Neurol Neurosurg Psychiatry; 2018 Feb 10; 89(2):219-220. PubMed ID: 28550070 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]